Literature DB >> 12653878

Life-threatening thrombotic complications of relative polycythaemia.

M Biswas1, P K Prakash, M Cossburn, K Myers, F Hanna.   

Abstract

Relative polycythaemia refers to raised haematocrit with normal red cell mass. Plasma volume may be reduced. This condition is associated with acute hypoxia, smoking, alcohol and diuretics. We describe two life-threatening thrombotic events in two patients with relative polycythaemia under age 40 years. The first had myocardial infarction and on admission haemoglobin was 21.6 g dL-1. The second developed pulmonary embolism and haemoglobin was 19.1 g dL-1. Both patients received antithrombotic measures and isovolumetric venesection. Sixteen patients (age <40 years) who attended our accident and emergency department in 1 year had a haemoglobin level of >18.0 g dL-1. Recognition of relative polycythaemia in at risk-individuals may help reduce thrombotic risk.

Entities:  

Mesh:

Year:  2003        PMID: 12653878     DOI: 10.1046/j.1365-2796.2003.01126.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  3 in total

1.  The Gaisbock syndrome after COVID-19 pneumonia.

Authors:  Abbie Evans; Busara Songtanin; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-01-13

Review 2.  Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.

Authors:  Douglas Tremblay; Abdulraheem Yacoub; Ronald Hoffman
Journal:  Hematol Oncol Clin North Am       Date:  2021-01-26       Impact factor: 3.722

3.  Relationship between the prevalence of polycythemia and factors observed in the mental health and lifestyle survey after the Great East Japan Earthquake.

Authors:  Akira Sakai; Hironori Nakano; Tetsuya Ohira; Masaharu Maeda; Kanako Okazaki; Atsushi Takahashi; Yukihiko Kawasaki; Hiroaki Satoh; Akira Ohtsuru; Michio Shimabukuro; Junichiro Kazama; Shigeatsu Hashimoto; Mitsuaki Hosoya; Seiji Yasumura; Hirooki Yabe; Hitoshi Ohto; Kenji Kamiya
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.